| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 99,209 | 109,517 | 75,255 | 39,052 |
| Restricted cash, current portion | 730 | 1,346 | NaN | NaN |
| Property and equipment, net | NaN | NaN | 2,895 | 3,407 |
| Prepaid expenses and other current assets | 2,258 | 3,232 | 2,453 | 2,034 |
| Total current assets | 102,197 | 114,095 | 77,708 | 41,086 |
| Restricted cash, net of current portion | 894 | 894 | 1,624 | 1,624 |
| Property and equipment, net | 1,927 | 2,339 | NaN | NaN |
| Operating lease right-of-use assets | 363 | 397 | 4,078 | 5,061 |
| Finance lease right-of-use assets | NaN | NaN | 90 | 97 |
| Other assets | 76 | 83 | NaN | NaN |
| Total assets | 105,457 | 117,808 | 86,395 | 51,275 |
| Accounts payable | 863 | 182 | 585 | 1,195 |
| Finance lease liabilities, current portion | NaN | NaN | 27 | 26 |
| Accrued expenses and other current liabilities | 4,302 | 5,632 | 4,065 | 2,870 |
| Current portion of deferred revenue | 11,075 | 9,387 | 0 | 0 |
| Operating lease liabilities, current portion | 384 | 286 | 3,226 | 3,147 |
| Financing liability, current portion | NaN | NaN | 0 | 97 |
| Other current liabilities | NaN | 27 | NaN | NaN |
| Total current liabilities | 16,624 | 15,514 | 7,903 | 7,335 |
| Deferred revenue, net of current portion | 5,215 | 8,113 | NaN | NaN |
| Operating lease liabilities, net of current portion | 1,738 | 1,688 | 3,046 | 3,892 |
| Finance lease liabilities, net of current portion | NaN | NaN | 47 | 59 |
| Derivative tranche liability | 50,948 | 44,760 | 16,732 | NaN |
| Other long-term liabilities | 30 | 29 | NaN | 2 |
| Total liabilities | 74,555 | 70,104 | 27,728 | 11,288 |
| Common stock, 0.0001 par value per share, 175,000,000 shares authorized as of march31, 2026 and december31, 2025, 51,925,800 and 51,902,614 shares issued and outstanding as of march31, 2026 and december31, 2025, respectively | 6 | 6 | 5 | 2 |
| Additional paid-in capital | 341,383 | 339,854 | 310,534 | 276,758 |
| Accumulated deficit | -310,487 | -292,156 | -251,872 | -236,773 |
| Total stockholders equity | 30,902 | 47,704 | 58,667 | 39,987 |
| Total liabilities and stockholders equity | 105,457 | 117,808 | 86,395 | 51,275 |
Camp4 Therapeutics Corp (CAMP)
Camp4 Therapeutics Corp (CAMP)